Ingelvac Provenza® addresses unmet needs for influenza A virus in swine (IAV-S) protection.

  • Ingelvac Provenza® protects against multiple IAV-S strains1
  • Decreases nasal shedding, which reduces transmission in a population1
  • Live attenuated influenza vaccine (LAIV) breaks through maternal antibodies to stimulate immunity2
  • Provides protection before pigs are most vulnerable (e.g., commingling, weaning)3
  • Intranasal administration provides protection at the site of natural IAV-S infection4,5
Ingelvac Provenza® 50 dose presentation photo
Healthy pigs


Are you located within the United States of America?

This is a required field

This website is an international information resource intended for veterinarians who are interested in information about Ingelvac Provenza® and influenza A virus in swine.

While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product label may not be the same in different countries.

INGELVAC Provenza® IS ONLY CURRENTLY LICENCED IN THE UNITED STATES OF AMERICA. Information on this website is derived from the product label in the USA.

By checking the box below, you are declaring and confirming that you are a veterinarian professional and that you have read and understood this disclaimer.

You must accept the terms and conditions and data policy to enter the website

Ingelvac Provenza is a trademark of Boehringer Ingelheim Vetmedica GmbH. © 2018 Boehringer Ingelheim Vetmedica, Inc.